Standard Life Aberdeen »

Zenas Biopharma shares owned by Standard Life Aberdeen

Quarter-by-quarter ownership of Zenas Biopharma shares owned by Standard Life Aberdeen from 13F filings

Historical chart of Standard Life Aberdeen investment in Zenas Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Zenas Biopharma held by Standard Life Aberdeen consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zenas Biopharma by Standard Life Aberdeen

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.3M 75k 16.92

More positions owned by Standard Life Aberdeen

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
UnitedHealth (UNH)
Broadcom (AVGO)
Mastercard Incorporated Cl A (MA)
Merck & Co (MRK)
Coca-Cola Company (KO)
Procter & Gamble Company (PG)

View all positions for Standard Life Aberdeen

Top funds holding Zenas Biopharma

NEA Management Company
Fairmount Funds Management
NVP Associates
Deerfield Management Company
Federated Investors
Novo A/S
Perceptive Advisors
Pivotal bioVenture Partners Investment Advisor
T. Rowe Price Associates
Arrowpoint Asset Management
Monashee Investment Management
Citadel Advisors
Standard Life Aberdeen
Point72 Asset Management
Soros Fund Management

View all funds holding Zenas Biopharma